GGrantIndex
← Leaderboards

Benjamin Francis Miller

Oklahoma Medical Research Foundation

$12,722,721
Attributed
$16,468,966
Total exposure
16
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,794,102 · 14
VA$0 · 3

By mechanism

R01$12,713,692 · 5
T32$1,552,551 · 1
P30$1,325,136 · 1
R56$767,685 · 1
R21$612,888 · 2
K01$611,820 · 1

Others in their field

Top investigators on “Aging

Research focus

AgingMitochondriaTissuesSkeletal MuscleAge RelatedResponseProtein DegradationProteomicsIn VivoMetabolicChronic DiseaseMitochondrial ProteinsProteinsInnovationProtein BiosynthesisPreventMaintenanceDesignSignal TransductionSirolimusDeteriorationExerciseLongevityAdult

Grant awards (45)

Multidimensional predictive modeling to understand mechanisms of exercise response heterogeneity in older adults$1,470,001
R01 · FY2025 · AG
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging$1,325,136
P30 · FY2025 · AG
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging$629,177
R01 · FY2025 · AG · contact PI
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan$584,218
R01 · FY2025 · AG · contact PI
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA$372,646
T32 · FY2025 · AG
53rd Annual Meeting of the American Aging Association$50,000
R13 · FY2025 · AG · contact PI
BCCMA: Recovery of Aged Muscle After Disuse Atrophy (REMEDY): Targeting energetics and proteostasis in recovery from disuse atrophy$0
I01 · FY2025 · VA
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy$0
I01 · FY2025 · VA · contact PI
Multidimensional predictive modeling to understand mechanisms of exercise response heterogeneity in older adults$1,545,208
R01 · FY2024 · AG
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging$649,901
R01 · FY2024 · AG · contact PI
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan$608,225
R01 · FY2024 · AG · contact PI
Does insulin sensitivity impact the potential of metformin to slow aging?$565,721
R01 · FY2024 · AG · contact PI
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA$335,203
T32 · FY2024 · AG
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy$0
I01 · FY2024 · VA · contact PI
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging$699,987
R01 · FY2023 · AG · contact PI
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan$614,408
R01 · FY2023 · AG · contact PI
Does insulin sensitivity impact the potential of metformin to slow aging?$566,743
R01 · FY2023 · AG · contact PI
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA$349,200
T32 · FY2023 · AG
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy$0
I01 · FY2023 · VA · contact PI
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging$660,106
R01 · FY2022 · AG · contact PI
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan$651,808
R01 · FY2022 · AG · contact PI
Does insulin sensitivity impact the potential of metformin to slow aging?$625,157
R01 · FY2022 · AG · contact PI
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA$495,502
T32 · FY2022 · AG
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy$0
I01 · FY2022 · VA · contact PI
Does insulin sensitivity impact the potential of metformin to slow aging?$631,878
R01 · FY2021 · AG · contact PI
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health$181,201
R21 · FY2021 · AR · contact PI
A novel approach to understand a mechanism of proteostatic decline with aging$767,685
R56 · FY2020 · AG · contact PI
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health$241,687
R21 · FY2020 · AR · contact PI
Does insulin sensitivity impact the potential of metformin to slow aging?$696,160
R01 · FY2019 · AG · contact PI
Translational mechanisms of mitochondrial protein synthesis$304,835
R01 · FY2017 · AG · contact PI
Dual treatment of sarcopenia and osteoarthritis with a Nrf2 activator$190,000
R21 · FY2017 · AG · contact PI
Assessment of proteostasis in cultured fibroblasts of short and long-lived species$75,917
R03 · FY2017 · AG · contact PI
Translational mechanisms of mitochondrial protein synthesis$304,835
R01 · FY2016 · AG · contact PI
Assessment of proteostasis in cultured fibroblasts of short and long-lived species$75,417
R03 · FY2016 · AG · contact PI
Translational mechanisms of mitochondrial protein synthesis$295,689
R01 · FY2015 · AG · contact PI
Translational mechanisms of mitochondrial protein synthesis$304,835
R01 · FY2014 · AG · contact PI
Translational mechanisms of mitochondrial protein synthesis$304,800
R01 · FY2013 · AG · contact PI
Tissue-specific mitochondrial turnover with aging and energy restriction$122,364
K01 · FY2013 · AG · contact PI
Tissue-specific mitochondrial turnover with aging and energy restriction$122,364
K01 · FY2012 · AG · contact PI
Tissue-specific mitochondrial turnover with aging and energy restriction$122,364
K01 · FY2011 · AG · contact PI
Tissue-specific mitochondrial turnover with aging and energy restriction$122,364
K01 · FY2010 · AG · contact PI
Tissue-specific mitochondrial turnover with aging and energy restriction$122,364
K01 · FY2009 · AG · contact PI
Turnover of Musculotendinous Collagen Following Exercise$6,246
F32 · FY2004 · AR
Turnover of Musculotendinous Collagen Following Exercise$2,750
F32 · FY2004 · AR